Advertisement
Research Article| Volume 27, ISSUE 1, P2-6, March 2016

Download started.

Ok

Anatomy, physiology, and genetics of paragangliomas

  • Yesul Kim
    Affiliations
    Division of Otolaryngology—Head and Neck Surgery, Penn State College of Medicine, Hershey, Pennsylvania
    Search for articles by this author
  • David Goldenberg
    Correspondence
    Address reprint requests and correspondence: David Goldenberg, MD, Division of Otolaryngology—Head and Neck Surgery, Department of Surgery, Penn State Hershey Medical Center, 500 University Dr, Hershey, PA 17033.
    Affiliations
    Division of Otolaryngology—Head and Neck Surgery, Penn State College of Medicine, Hershey, Pennsylvania
    Search for articles by this author
Published:December 16, 2015DOI:https://doi.org/10.1016/j.otot.2015.12.003
      Paragangliomas arise from an extra-adrenal paraganglionic cells, derived from the neural crest of the autonomic nervous system and make up the most common class of benign vascular neoplasms of the neck. PGLs of the head and neck originate most commonly from the paraganglia within the carotid body, the jugular foramen, the middle ear and the vagus nerve. Knowledge of the embryology, anatomy and genetics of these rare tumors is paramount to successful diagnosis and treatment of head and neck paragangliomas.

      Keywords

      Paragangliomas (PGLs) arise from an extra-adrenal paraganglionic cells, derived from the neural crest of the autonomic nervous system and make up the most common class of benign vascular neoplasms of the neck.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      PGLs can be divided into the following 2 groups: sympathetic-derived and parasympathetic-derived tumors.
      • Pellitteri P.K.
      • Rinaldo A.
      • Myssiorek D.
      • et al.
      Paragangliomas of the head and neck.
      Tumors in the thorax, abdomen, and pelvis are usually derived from sympathetic paraganglia, and are more often associated with catecholamine production.
      • Hussain I.
      • Husain Q.
      • Baredes S.
      • et al.
      Molecular genetics of paragangliomas of the skull base and head and neck region: Implications for medical and surgical management.
      Pheochromocytomas are histologically similar to sympathetic PGLs, and arise in the adrenal gland.
      • Hussain I.
      • Husain Q.
      • Baredes S.
      • et al.
      Molecular genetics of paragangliomas of the skull base and head and neck region: Implications for medical and surgical management.
      On the other hand, head and neck region PGLs (HNPGLs) are most often benign, slowly progressing, derived from parasympathetic paraganglia and rarely secrete catecholamines.
      • Hussain I.
      • Husain Q.
      • Baredes S.
      • et al.
      Molecular genetics of paragangliomas of the skull base and head and neck region: Implications for medical and surgical management.
      • Taïeb D.
      • Varoquaux A.
      • Chen C.C.
      • Pacak K.
      Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.
      PGLs represent an estimated 0.01% of human tumors.
      • Martin T.P.
      • Irving R.M.
      • Maher E.R.
      The genetics of paragangliomas: A review.
      Pheochromocytomas make up approximately 90% of tumors arising from the paraganglion system and the remaining 10% arise from extra-adrenal sites, with 85% arising in the abdomen, 12% in the thorax, and the remaining 3% in the head and neck area.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      PGLs of the head and neck originate most commonly from the paraganglia within the carotid body, the jugular foramen, the middle ear (tympanicum), and the vagus nerve (Figure 1).
      Figure thumbnail gr1
      Figure 1Common locations of paragangliomas of the head and neck.

      Carotid body

      The carotid body is the most common location for HNPGLs.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      The carotid body, located in the adventitia of the posteromedial aspect of the carotid artery bifurcation, is a chemoreceptor that modulates respiratory and cardiovascular function in response to pH, oxygen, carbon dioxide tension changes.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      Low pH and low oxygen stimulate the carotid body to initiate an autonomic response to increase respiratory rate, heart rate, blood pressure, and cerebral cortical activity
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      (Figure 2). Most carotid body tumors (CBTs) are nonfunctional, nonsymptomatic, and slow growing.
      • Ikejiri K.
      • Muramori K.
      • Takeo S.
      • et al.
      Functional carotid body tumor: Report of a case and a review of the literature.
      • Zeng G.
      • Zhao J.
      • Ma Y.
      • et al.
      A comparison between the treatments of functional and nonfunctional carotid body tumors.
      CBTs usually present as a lateral cervical mass, which is mobile laterally but less mobile cranio-caudally owing to its adherence to carotid arteries.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      As they enlarge, 10% of patients may present with symptoms of dysphagia, odynophagia, hoarseness, and other cranial nerve (CN) deficits.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      Moreover, carotid sinus syndrome syncope, which is a loss of consciousness and reflex bradycardia and hypertension, has been described to be associated with CBTs.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      However, some CBTs may be functional, which means they are able to synthesize catecholamines, and therefore may lead to symptoms such as heart palpitations, dizziness, headache, and hypertension.
      • Zeng G.
      • Zhao J.
      • Ma Y.
      • et al.
      A comparison between the treatments of functional and nonfunctional carotid body tumors.
      Figure thumbnail gr2
      Figure 2The bifurcation of the common carotid artery, demonstrating baroreceptors in the wall of the carotid sinus and chemoreceptors within the carotid body.
      The right common carotid artery originates from the brachiocephalic trunk immediately posterior to the right sternoclavicular joint, whereas the left common carotid artery begins in the thorax as a direct branch of the arch of the aorta and passes superiorly to enter the neck near the left sternoclavicular joint.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The right and left common carotid arteries ascend lateral to the trachea and esophagus within the carotid sheath.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      Each common carotid artery then divides into its 2 terminal branches, the external and internal carotid arteries.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      At the bifurcation, the origin of the internal carotid artery is dilated. This dilation is the carotid sinus, which has receptors that monitor blood pressure.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The carotid body is another accumulation of receptors in the area of the bifurcation and is responsible for detecting changes in blood chemistry, particularly the oxygen content.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The carotid body is innervated by branches from both the glossopharyngeal (IX) and vagus (X) nerves.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.

      Jugular foramen

      Jugular PGLs, the second most common HNPGL, arise from paraganglia in or around the jugular bulb along Jacobson nerve (CN IX) or Arnold nerve (X).
      • Jackson C.G.
      Glomus tympanicum and glomus jugulare tumors.
      • Rosenwasser H.
      Glomus jugulare tumors. I. Historical background.
      Pulsatile tinnitus is the most frequent symptom, and conductive hearing loss is seen with the progression of the tumor, which either causes impairment of ossicles vibration or invades bones behind the eardrum.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      When the tumor invades the inner ear, sensorineural hearing loss and dizziness is reported.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      Moreover, jugular PGLs can cause deficits of other cranial nerves and dysfunctional swallowing and hoarseness.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      Upon further growth of these tumors, they can also invade the facial nerve, which can lead to facial paralysis or invade the hypoglossal nerve, leading to paralysis of the tongue
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      (Figure 3).
      Figure thumbnail gr3
      Figure 3Jugular paragangliomas arise from paraganglia tissue in or around the jugular bulb.
      The jugular foramen is located in the floor of the posterior fossa, posterolateral to the carotid canal, and between the petrous temporal bone and occipital bone.
      • Aschenbach R.
      • Basche S.
      • Vogl T.J.
      • et al.
      Diffusion-weighted imaging and ADC mapping of head-and-neck paragangliomas: Initial experience.
      A complex canal of neurovascular structures in the skull base, the jugular foramen is divided into the pars nervosa (anteromedial) and the pars vascularis (posterolateral).
      • Aschenbach R.
      • Basche S.
      • Vogl T.J.
      • et al.
      Diffusion-weighted imaging and ADC mapping of head-and-neck paragangliomas: Initial experience.
      The pars nervosa contains the glossopharyngeal (IX) with Jacobson nerve and the pars vascularis contains the internal jugular vein, vagus nerve (X), and spinal accessory (XI).
      • Aschenbach R.
      • Basche S.
      • Vogl T.J.
      • et al.
      Diffusion-weighted imaging and ADC mapping of head-and-neck paragangliomas: Initial experience.

      Tympanicum

      Tympanic PGLs originate from the middle ear.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      They arise along Jacobson nerve (inferior tympanic nerve to branch of CN IX). These small-sized tumors become symptomatic as pulsatile tinnitus in most patients.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      Most tympanic PGLs are visible as a vascular middle ear mass and diagnosed by examining the tympanic membrane and eardrum.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      The external acoustic meatus is separated from the middle ear by the tympanicum membrane.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The tympanic membrane consists of 3 layers as follows: an outer (cutaneous), intermediate (fibrous), and inner (mucous) layer. A thickened fibrocartilaginous ring attaches the periphery of the tympanic membrane to the tympanic part of the temporal bone. A central concavity is produced by the attachment on its internal surface of the lower end of the handle of the malleus called the umbo of the tympanic membrane.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The bright reflection of light that is anteroinferior to the umbo of the tympanic membrane is the cone of light.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      When tympanic PGL is present otoscopic examination may reveal a characteristic, pulsatile, reddish-blue tumor behind the tympanic membrane. The tympanic membrane may pulsate, if the PGL is touching the under surface of the intact eardrum. Anterosuperior to the umbo is the attachment of the rest of the handle of the malleus and at the most superior extent of this line of attachment is a small bulge in the membrane called the lateral process of the malleus.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.

      Vagus nerve

      Vagal PGLs are the rarest of major HNGPLs.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      They are benign vascular tumors from glomus bodies and arise from the inferior, middle, or superior vagal ganglia
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      (Figure 4). Most vagal PGLs arise from glomus nodosum, which is the inferior ganglion.
      Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      Vagal PGLs may present with deficits of cranial nerves, which manifests as hoarseness, tinnitus, and hearing loss.
      • Shin S.H.
      • Piazza P.
      • De Donato G.
      • et al.
      Management of vagal paragangliomas including application of internal carotid artery stenting.
      In 22% of cases, vagal PGLs can cause intracranial extension, and death.
      • Netterville J.L.
      • Jackson C.G.
      • Miller F.R.
      • et al.
      Vagal paraganglioma: A review of 46 patients treated during a 20-year period.
      Figure thumbnail gr4
      Figure 4Anatomy of the vagus nerve as it relates to vagal paragangliomata (X).
      Within the carotid sheath is the vagus nerve, which lies between and posterior to the internal jugular vessels.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The vagus nerve arises as a group of rootlets on the anterolateral surface of medulla oblongata just inferior to the rootlets arising to form the glossopharyngeal nerve (IX).
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      The rootlets cross the posterior cranial fossa and enter the jugular foramen where it merges to form the vagus nerve (X).
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.
      Within or immediately outside of the jugular foramen are the superior (jugular) and inferior (nodose) ganglia, which contain the cell bodies of the sensory neurons in the vagus nerve.
      • Drake R.L.
      • Vogl A.W.
      • Mitchell A.W.M.

      Genetics of PGLs

      In contrast to HNPGLs, pheochromocytomas and sympathetic PGLs are more frequently seen in inherited cancer predisposition syndromes, such as multiple endocrine neoplasia Type 2, neurofibromatosis Type 1, and von-Hippel-Lindau disease.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      • Boedeker C.C.
      • Erlic Z.
      • Richard S.
      • et al.
      Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
      However, up to 30% of HNPGLs have a distinct familial component,
      • Taïeb D.
      • Varoquaux A.
      • Chen C.C.
      • Pacak K.
      Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.
      although most HNPGLs arise sporadically. Mutations in genes coding for the succinate dehydrogenase (SDH) enzyme complex, have been found to be the most significant drivers of PGL tumorigenesis.
      • Taïeb D.
      • Varoquaux A.
      • Chen C.C.
      • Pacak K.
      Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.
      SDH is not only an important enzyme in the mitochondrial tricarboxylic acid cycle but also is a component of the electron transport chain and oxidative phosphorylation. Therefore, SDH is important in adenosine triphosphate generation.
      • Hensen E.F.
      • Bayley J.P.
      Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.
      Mutations in SDHx genes result in a pseudohypoxic state and upregulate hypoxia-inducible factor 1-alpha transcription factors and downstream targets
      • Tsang V.H.
      • Dwight T.
      • Benn D.E.
      • et al.
      Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
      owing to the accumulation of succinate and generation of reactive oxygen species. Moreover, the accumulation of succinate is associated with the depletion of fumarate, limited capacity to use oxidative phosphorylation for adenosine triphosphate production, accelerated cell proliferation and growth, and tumor development.
      • Hussain I.
      • Husain Q.
      • Baredes S.
      • et al.
      Molecular genetics of paragangliomas of the skull base and head and neck region: Implications for medical and surgical management.
      Genetic mutations responsible for the hereditary form of PGL syndromes have been identified in genes coding for SDH-subunit D, B, and C genes. Hereditary PGL syndrome has been classified genetically into 4 entities—PGL1-4.
      • Burnichon N.
      • Abermil N.
      • Buffet A.
      • et al.
      The genetics of paragangliomas.
      The 4 chromosomal regions with a PGL locus were first identified via genetic linkage studies on large Dutch, American, and German families.
      • Burnichon N.
      • Abermil N.
      • Buffet A.
      • et al.
      The genetics of paragangliomas.
      The PGL1 locus is situated on chromosomal band 11q21,
      • Baysal B.E.
      • van Schothorst E.M.
      • Farr J.E.
      • et al.
      Repositioning the hereditary paraganglioma critical region on chromosome band 11q23.
      PGL2 on 11q13,
      • Mariman E.C.
      • van Beersum S.E.
      • Cremers C.W.
      • et al.
      Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: Evidence for genetic heterogeneity.
      PGL3 on 1q21,
      • Niemann S.
      • Becker-Follmann J.
      • Nürnberg G.
      • et al.
      Assignment to PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma.
      and PGL4 on 1p36.
      • Astuti D.
      • Latif F.
      • Dallol A.
      • et al.
      Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
      The genes carried by these 4 loci have been identified over the last decade as follows: SDHD for PGL1,
      • Baysal B.E.
      • Ferrell R.E.
      • Willett-Brozick J.E.
      • et al.
      Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
      SDHAF2 for PGL2,
      • Hao H.X.
      • Khalimonchuk O.
      • Schraders M.
      • et al.
      SDH5, a gene required for flavination of succinate dehydrogenase is mutated in paraganglioma.
      SDHC for PGL3,
      • Niemann S.
      • Müller U.
      Mutations in SDHC cause autosomal dominant paraganglioma type 3.
      and SDHB for PGL4.
      • Astuti D.
      • Latif F.
      • Dallol A.
      • et al.
      Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
      Of all the known genetic mutations, mutations in SDHD are currently the leading cause of hereditary HNPGLs.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      • Piccini V.1
      • Rapizzi E.
      • Bacca A.
      • et al.
      Head and neck paragangliomas: Genetic spectrum and clinical variability in 79 consecutive patients.
      PGL1, which is caused by mutations in the D subunit of SDHx gene, is the most common inherited genetic abnormality in familial PGL.
      • Offergeld C.
      • Brase C.
      • Yaremchuk S.
      • et al.
      Head and neck paragangliomas: Clinical and molecular genetic classification.
      • Piccini V.1
      • Rapizzi E.
      • Bacca A.
      • et al.
      Head and neck paragangliomas: Genetic spectrum and clinical variability in 79 consecutive patients.
      PGL1 is autosomal dominant and modified by genomic imprinting.
      • van der Mey A.G.
      • Maaswinkel-Mooy P.D.
      • Cornelisse C.J.
      • et al.
      Genomic imprinting in hereditary glomus tumours: Evidence for new genetic theory.
      Genes associated with SDHA, SDHB, SDHC, SDHD, and SDHAF2 are tumor suppressors that exhibit loss of heterozygosity, which in turn destabilizes the SDH complex and diminishes enzymatic activity.
      • Douwes Dekker P.B.
      • Hogendoorn P.C.
      • Kuipers-Dijkshoorn N.
      • et al.
      SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology.
      SDHA is a flavoprotein, SDHB, an iron-sulfur protein, which form the main catalytic domain. SDHC and SDHD are membrane-anchoring subunits of SDH that play a role in electron transport. Although these SDH proteins are components of the same complex, each mutation lead to differences in clinical phenotype.
      • Hensen E.F.
      • Bayley J.P.
      Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.

      Succinate dehydrogenase complex subunit D

      Mutations in the oxidative chain protein, SDH-subunit D were the first mutations to be described in families with inherited PGs.
      • Hensen E.F.
      • Bayley J.P.
      Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.
      Although SDHD mutations can be inherited both maternally and paternally, HNPGLs almost never develop via maternal transmission of mutation.
      • Neumann H.P.
      • Pawlu C.
      • Peczkowska M.
      • et al.
      Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
      • Bayley J.P.1
      • Oldenburg R.A.
      • Nuk J.
      • et al.
      Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.
      This phenomenon is explained by the fact that the whole maternal copy of chromosome 11 is selectively loss in SDHD-linked paraganglial tumors.
      • Hensen E.F.
      • Jordanova E.S.
      • van Minderhout I.J.
      Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.
      SDHD mutations are associated with a high-tumor penetrance, although not all carriers with a tumor develop additional tumor-related symptoms.
      • Neumann H.P.
      • Pawlu C.
      • Peczkowska M.
      • et al.
      Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
      Furthermore, it has been demonstrated that more egregious mutations, such as splice site and nonsense mutations, result in not only earlier onset but also increased risk of developing multiple HNPGLs and pheochromocytomas.
      • Neumann H.P.
      • Pawlu C.
      • Peczkowska M.
      • et al.
      Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

      Succinate dehydrogenase complex subunit B

      SDHB, which codes for subunit B of SDH complex, is also known as iron-sulfur subunit of mitochondrial complex II. In contrast to SDHD mutation carriers (PGL1) with more frequent multifocal PGLs, SDHB mutation carriers (PGL4) are more likely to develop malignant disease and possibly extraparaganglial neoplasias, including renal cell and thyroid carcinomas.
      • Neumann H.P.
      • Pawlu C.
      • Peczkowska M.
      • et al.
      Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

      Succinate dehydrogenase complex subunit C

      SDHC codes for SDH complex subunit C, which is an integral membrane protein found on chromosome 1. Mutations in SDHC are rarer than those of SDHB and SDHD and contrary to patients with PGL1 and PGL4, SDHC mutation carriers mostly present with benign, single HNPGs.
      • Neumann H.P.H.
      • Erlic Z.
      • Boedeker C.C.
      • et al.
      Clinical predictors for germline mutations in head and neck paraganglioma patients: Cost reduction strategy in genetic diagnostic process as fall-out.

      Succinate dehydrogenase complex assembly factor 2

      SDHAF2 (also referred to as SDH5) is a protein involved in the addition of flavin-adenine dinucleotide prosthetic group of SDHA. SDHAF2 mutations lead to SDH complex instability and reduction in enzymatic activity.
      • Hao H.X.
      • Khalimonchuk O.
      • Schraders M.
      • et al.
      SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
      Moreover, SDHAF2 mutations have a very high penetrance
      • Hensen E.F.
      • Bayley J.P.
      Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.
      , which usually lead to familial presentation. However, SDHAF2 mutations are a rare cause of HNPGL.
      • Bayley J.P.
      • Kunst H.P.
      • Cascon A.
      • et al.
      SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.

      Succinate dehydrogenase complex subunit A

      Within the SDH complex, SDHA is the largest gene, protein, and major catalytic subunit of the enzyme. However, SDHA mutations have only been recently described in small subsets of PGLs and pheochromocytomas (<3%).
      • Korpershoek E.1
      • Favier J.
      • Gaal J.
      • et al.
      SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
      Owing to the known genetic mutations related to HNPGLs, genetic testing for PGL is now an important part of diagnostic management and care for familial PGLs.

      Disclosure

      The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

      References

      1. Day TA, Buchmann L, Rumboldt Z, et al: Head and Neck Surgery and Oncology. Year; 118: 1656-1662
        • Pellitteri P.K.
        • Rinaldo A.
        • Myssiorek D.
        • et al.
        Paragangliomas of the head and neck.
        Oral Oncol. 2004; 40: 563-575
        • Hussain I.
        • Husain Q.
        • Baredes S.
        • et al.
        Molecular genetics of paragangliomas of the skull base and head and neck region: Implications for medical and surgical management.
        J Neurosurg. 2014; 120: 321-330
        • Taïeb D.
        • Varoquaux A.
        • Chen C.C.
        • Pacak K.
        Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.
        Semin Nucl Med. 2013; 43: 462-473
        • Martin T.P.
        • Irving R.M.
        • Maher E.R.
        The genetics of paragangliomas: A review.
        Clin Otolaryngol. 2007; 32: 7-11
        • Ikejiri K.
        • Muramori K.
        • Takeo S.
        • et al.
        Functional carotid body tumor: Report of a case and a review of the literature.
        Surgery. 1996; 119: 222-225
        • Zeng G.
        • Zhao J.
        • Ma Y.
        • et al.
        A comparison between the treatments of functional and nonfunctional carotid body tumors.
        Ann Vasc Surg. 2012; 26: 506-510
        • Drake R.L.
        • Vogl A.W.
        • Mitchell A.W.M.
        (ed 3). Gray׳s Anatomy for Students. 8. Churchill Livingstone, Elsevier, Philadelphia2014: 863-1163
        • Jackson C.G.
        Glomus tympanicum and glomus jugulare tumors.
        Otolaryngol Clin North Am. 2001; 34: 941-970
        • Rosenwasser H.
        Glomus jugulare tumors. I. Historical background.
        Arch Otolaryngol. 1968; 88: 1-40
        • Offergeld C.
        • Brase C.
        • Yaremchuk S.
        • et al.
        Head and neck paragangliomas: Clinical and molecular genetic classification.
        Clinics. 2012; 67: 19-28
        • Aschenbach R.
        • Basche S.
        • Vogl T.J.
        • et al.
        Diffusion-weighted imaging and ADC mapping of head-and-neck paragangliomas: Initial experience.
        Klin Neuroradiol. 2009; 19: 215-219
        • Shin S.H.
        • Piazza P.
        • De Donato G.
        • et al.
        Management of vagal paragangliomas including application of internal carotid artery stenting.
        Audiol Neurootol. 2012; 17: 39-53
        • Netterville J.L.
        • Jackson C.G.
        • Miller F.R.
        • et al.
        Vagal paraganglioma: A review of 46 patients treated during a 20-year period.
        Arch Otolaryngol Head Neck Surg. 1998; 124: 1133-1140
        • Boedeker C.C.
        • Erlic Z.
        • Richard S.
        • et al.
        Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
        J Clin Endocrinol Metab. 2009; 94: 1938-1944
        • Hensen E.F.
        • Bayley J.P.
        Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.
        Fam Cancer. 2011; 10: 355-363
        • Tsang V.H.
        • Dwight T.
        • Benn D.E.
        • et al.
        Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
        Endocr Relat Cancer. 2014; 21: 415-426
        • Burnichon N.
        • Abermil N.
        • Buffet A.
        • et al.
        The genetics of paragangliomas.
        Eur Ann Otorhinolaryngol Head Neck Dis. 2012; 129: 315-318
        • Baysal B.E.
        • van Schothorst E.M.
        • Farr J.E.
        • et al.
        Repositioning the hereditary paraganglioma critical region on chromosome band 11q23.
        Hum Genet. 1999; 104: 219-225
        • Mariman E.C.
        • van Beersum S.E.
        • Cremers C.W.
        • et al.
        Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: Evidence for genetic heterogeneity.
        Hum Genet. 1995; 95: 56-62
        • Niemann S.
        • Becker-Follmann J.
        • Nürnberg G.
        • et al.
        Assignment to PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant non-chromaffin paraganglioma.
        Am J Med Genet. 2001; 98: 32-36
        • Astuti D.
        • Latif F.
        • Dallol A.
        • et al.
        Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
        Am J Hum Genet. 2001; 69: 49-54
        • Baysal B.E.
        • Ferrell R.E.
        • Willett-Brozick J.E.
        • et al.
        Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
        Science. 2000; 287: 848-851
        • Hao H.X.
        • Khalimonchuk O.
        • Schraders M.
        • et al.
        SDH5, a gene required for flavination of succinate dehydrogenase is mutated in paraganglioma.
        Science. 2009; 325: 1139-1142
        • Niemann S.
        • Müller U.
        Mutations in SDHC cause autosomal dominant paraganglioma type 3.
        Nat Genet. 2000; 26: 268-270
        • Piccini V.1
        • Rapizzi E.
        • Bacca A.
        • et al.
        Head and neck paragangliomas: Genetic spectrum and clinical variability in 79 consecutive patients.
        Endocr Relat Cancer. 2012; 19: 149-155
        • van der Mey A.G.
        • Maaswinkel-Mooy P.D.
        • Cornelisse C.J.
        • et al.
        Genomic imprinting in hereditary glomus tumours: Evidence for new genetic theory.
        Lancet. 1989; 2: 1291-1294
        • Douwes Dekker P.B.
        • Hogendoorn P.C.
        • Kuipers-Dijkshoorn N.
        • et al.
        SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology.
        J Pathol. 2003; 201: 480-486
        • Neumann H.P.
        • Pawlu C.
        • Peczkowska M.
        • et al.
        Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
        J Am Med Assoc. 2004; 292: 943-951
        • Bayley J.P.1
        • Oldenburg R.A.
        • Nuk J.
        • et al.
        Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.
        BMC Med Genet. 2014; 15: 111
        • Hensen E.F.
        • Jordanova E.S.
        • van Minderhout I.J.
        Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families.
        Oncogene. 2004; 23: 4076-4083
        • Neumann H.P.H.
        • Erlic Z.
        • Boedeker C.C.
        • et al.
        Clinical predictors for germline mutations in head and neck paraganglioma patients: Cost reduction strategy in genetic diagnostic process as fall-out.
        Cancer Res. 2009; 69: 3650-3656
        • Hao H.X.
        • Khalimonchuk O.
        • Schraders M.
        • et al.
        SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.
        Science. 2009; 325: 1139-1142
        • Bayley J.P.
        • Kunst H.P.
        • Cascon A.
        • et al.
        SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
        Lancet Oncol. 2010; 11: 366-372
        • Korpershoek E.1
        • Favier J.
        • Gaal J.
        • et al.
        SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas.
        J Clin Endocrinol Metab. 2011;; 96: 1472-1476